IDEAYA Biosciences, Inc (IDYA) Stock Price

34.50 ▲ +1.46 (+4.42%)
Open: 35.34 Vol: 0 Day's range: 33.88 - 35.63 Mar 03, 11:22 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
IDYA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 34.60▲ 34.55▲ 34.01▲ 32.70▲ 32.26▲
MA10 34.53▲ 33.85▲ 33.20▲ 32.35▲ 33.54▲
MA20 34.42▲ 33.00▲ 32.62▲ 32.25▲ 33.35▲
MA50 33.92▲ 32.28▲ 32.20▲ 34.00▲ 26.66▲
MA100 33.09▲ 32.21▲ 31.83▲ 32.91▲ 29.17▲
MA200 32.54▲ 31.86▲ 32.84▲ 28.10▲ 26.08▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.010▼ 0.196▲ 0.274▲ 0.341▲ -0.517▼
RSI 60.443▲ 69.430▲ 74.320▲ 59.509▲ 58.572▲
STOCH 74.926     64.867     82.952▲ 69.586     21.614    
WILL %R -9.649▲ -27.601     -21.779▲ -15.635▲ -46.932    
CCI 109.542▲ 99.847     135.695▲ 267.375▲ -4.887    
Latest Filters Detected On IDYA
MA $IDYA Price Crossed Above MA(50) Set Alert
▲ GAP $IDYA Open Gap Up %5 Set Alert
▲ GAP $IDYA Open Gap Up %3 Set Alert
▲ GAP $IDYA Open Gap Up %2 Set Alert
▲ BREAK $IDYA Price Breaks 20 Days High Set Alert
▲ BREAK $IDYA Price Breaks 10 Days High Set Alert
IDEAYA Biosciences, Inc News
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
Friday, February 27, 2026 04:24 PM
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with ...
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
Wednesday, February 25, 2026 03:41 AM
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that the first patient has been enrolled in its Phase 1 dose escalation/expansion trial ...
IDEAYA Biosciences Teases Late-March Phase III Darovasertib Readout, ADC Updates, New KAT6/7 Phase I Launch
Monday, February 23, 2026 11:47 AM
IDEAYA Biosciences (NASDAQ:IDYA) outlined upcoming clinical milestones for its precision oncology pipeline, emphasizing an imminent top-line readout in first-line metastatic uveal melanoma (MUM), ...
IDYA historical stock data
date open high low close volume
03/03/26 35.35 35.64 33.88 34.675 0
02/03/26 31.81 33.59 31.19 33.04 828,639
27/02/26 31.65 32.305 31.65 32.20 753,037
26/02/26 31.67 32.195 31.00 31.90 775,948
25/02/26 32.21 32.95 31.58 31.67 789,319
24/02/26 32.475 32.8799 31.61 32.07 715,819
23/02/26 32.04 33.31 31.45 32.11 0
20/02/26 32.90 32.93 31.58 31.98 805,701
19/02/26 31.06 33.025 30.81 32.90 1,118,833
18/02/26 30.55 31.23 30.53 30.92 850,928
Quote Details
52wk Low:13.45
52wk High:39.28
Vol:0
Avg Vol(3m):11.6M
1Y Chng:+90.42%
1M Chng:-3.01%
Add to Watch List
More Information
Index US Composite
Market Cap. 2.83B